EVOLUS, INC. Earnings Per Share, Basic and Diluted
EVOLUS, INC. (EOLS) reported Earnings Per Share, Basic and Diluted of -$4.83 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-25
- EVOLUS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.34.
- EVOLUS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.63.
- EVOLUS, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.59.
- EVOLUS, INC. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.98.
- EVOLUS, INC. earnings per share, basic and diluted for fiscal 2020 was -$4.83.
- EVOLUS, INC. earnings per share, basic and diluted for fiscal 2019 was -$3.19.
- EVOLUS, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.92.
- EVOLUS, INC. earnings per share, basic and diluted for fiscal 2017 was -$0.27.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$4.83 10-K · filed 2021-03-25 | |||
| 2020-09-30 | -$0.34 10-Q · filed 2020-10-29 | -$1.55 10-Q · filed 2020-10-29 | ||
| 2020-06-30 | -$0.63 10-Q · filed 2020-08-10 | -$1.21 10-Q · filed 2020-08-10 | ||
| 2020-03-31 | -$0.59 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | -$3.19 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$0.98 10-Q · filed 2020-10-29 | -$2.76 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | -$1.37 10-Q · filed 2020-08-10 | -$1.77 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | -$0.40 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | -$1.92 10-K · filed 2020-02-25 | |||
| 2018-09-30 | -$0.48 10-Q · filed 2019-11-04 | -$1.47 10-Q · filed 2019-11-04 | ||
| 2018-06-30 | -$0.69 10-Q · filed 2019-08-12 | -$1.03 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$0.30 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | -$0.27 10-K · filed 2019-03-20 | |||
| 2017-09-30 | -$0.16 10-Q · filed 2018-11-05 | -$0.54 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | -$0.14 10-Q · filed 2018-08-02 | -$0.38 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | -$0.24 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |